BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9789214)

  • 1. Genetic abnormalities in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M
    Med Oncol; 1998 Jul; 15(2):79-88. PubMed ID: 9789214
    [No Abstract]   [Full Text] [Related]  

  • 2. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
    Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic and molecular characterization of non-Hodgkin's lymphoma.
    Gaidano G; Dalla-Favera R
    Curr Opin Oncol; 1993 Sep; 5(5):776-84. PubMed ID: 8218489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of genetic material from the short arm of chromosome 12 is a frequent secondary abnormality in non-Hodgkin's lymphoma.
    Jonveaux P; Le Coniat M; Derré J; Vecchione D; Berger R
    Hematol Pathol; 1991; 5(1):21-6. PubMed ID: 2050601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases.
    van Krieken JH; McKeithan TW; Raghoebier S; Medeiros LJ; Kluin PM; Raffeld M
    Leukemia; 1990 Dec; 4(12):811-2. PubMed ID: 2243504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some recent aspects of the molecular biology of human lymphoma.
    Larsen CJ; Seite P; Hillion J; D'Agay MF; Berger R
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):37-40. PubMed ID: 8511039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
    Weiss LM; Warnke RA; Sklar J; Cleary ML
    N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomas.
    Howard OM; Shipp MA
    Curr Opin Oncol; 1998 Sep; 10(5):385-91. PubMed ID: 9800106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
    Babu Rao V; Kerketta L; Madkaikar M; Farah J; Ghosh K
    Acta Haematol; 2006; 116(2):150-2. PubMed ID: 16914914
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: relationship to smoking.
    Nandi S; Yu J; Burger AM; Reinert LS; Gartenhaus RB
    Leuk Lymphoma; 2006 Sep; 47(9):1806-12. PubMed ID: 17064992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways in low grade B-cell lymphoma.
    Gaidano G; Pastore C; Capello D; Cilli V; Saglio G
    Leuk Lymphoma; 1997 Dec; 26 Suppl 1():107-13. PubMed ID: 9570687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukaemia to non-Hodgkin's lymphoma.
    Qian L; Gong J; Liu J; Broome JD; Koduru PR
    Br J Haematol; 1999 Aug; 106(2):477-85. PubMed ID: 10460609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
    García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
    Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.
    Athan E; Foitl DR; Knowles DM
    Am J Pathol; 1991 Mar; 138(3):591-9. PubMed ID: 1900388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
    Goldin LR; Björkholm M; Kristinsson SY; Turesson I; Landgren O
    Haematologica; 2009 May; 94(5):647-53. PubMed ID: 19286886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 14: a breakpoint in non-Hodgkin's lymphomas.
    van 't Veer MB
    Neth J Med; 1990 Aug; 37(1-2):37-43. PubMed ID: 2215832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
    Ma ES
    Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.